4-Aminopyridine antagonizes saxitoxin- and tetrodotoxin-induced cardiorespiratory depression

Toxicon

Volumn 34, Issue 6, 1996, Pages 671-690

  Chang, Fat Chun T ^a   Bauer, Robert M ^a   Benton, Bernard J ^a   Keller, Shannon A ^a   Capacio, Benedict R ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; SAXITOXIN; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CARDIOTOXICITY; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; GUINEA PIG; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATION DEPRESSION;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0030175764     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/0041-0101(95)00167-0     Document Type: Article

References (44)

1. Benton B. J., Rivera V. R., Hewetson J. F. and Chang F.-C. T. (1994) Reversal of saxitoxin-induced cardio-respiratory failure by a burro-raised α-STX antibody and oxygen therapy. Toxic. appl. Pharmac. 124, 39-51.
2. Borison H. L. and McCarthy L. E. (1977) Respiratory and circulatory effects of saxitoxin in the cerebrospinal fluid. Br. J. Pharmac. 61, 679-689.
3. Borison H. L., Culp W. J., Gonsalves S. F. and McCarthy L. E. (1980) Central respiratory and circulatory depression caused by intravascular saxitoxin. Br. J. Pharmac. 68, 301-309.
4. Bowman W. C. and Savage A. O. (1981) Pharmacology of aminopyridines and related compounds. Rev. Pure appl. Pharmac. Sci. 2, 317-371.
5. Chang F.-C. T. and Harper R. M. (1989) A procedure for chronic recording of diaphragmatic electromyographic activity. Brain Res. Bull. 22, 561-563.
6. Chang F.-C. T., Scott T. R. and Harper R. M. (1988) Methods of single unit recording from medullary neural substrates in awake, behaving animals. Brain Res. Bull. 21, 749-756.
7. Chang F.-C. T., Benton B. J., Salyer J. L., Foster R. E. and Franz D. R. (1990) Respiratory and cardiovascular effects of tetrodotoxin (TTX) in urethane-anesthetized guinea pigs. Brain Res. 528, 259-268.
8. Chang F.-C. T., Benton B. J., Lenz R. A. and Capacio B. R. (1993) Central and peripheral cardio-respiratory effects of saxitoxin (STX) in urethane-anesthetized guinea pigs. Toxicon 31, 645-664.
9. Chesnut T. J. and Swann J. W. (1990) Suppression of 4-aminopyridine-induced epileptogenesis by the GABAA agonist muscimol. Epilepsy Res. 5, 8-17.
10. Childers, D. G. (1978) Modern Spectrum Analysis. New York: IEEE Press.
11. Davio S. R. (1985) Neutralization of saxitoxin by anti-saxitoxin rabbit serum. Toxicon 23, 669-675.
12. Evans M. H. (1972) Tetrodotoxin, saxitoxin, and related substances: their application in neurobiology. Int. Rev. Neurobiol. 15, 83-165.
13. Field K. J., White W. J. and Lang C. M. (1993) Anaesthetic effects of chloral hydrate, pentobarbitone and urethane in adult male rats. Lab. Animals 27, 258-269.
14. Flachsenberger W. A. (1987) Respiratory failure and lethal hypotension due to blue ringed octopus and tetrodotoxin envenomation observed and counteracted in animal models. Clin. Toxic. 24, 485-502.
15. Folgering H., Rutten J. and Agoston S. (1979) Stimulation of phrenic nerve activity by an acetylcholine releasing drug: 4-aminopyridine. Pflügers Arch. ges. Physiol. 379, 181-185.
16. Franz D. R. and LeClaire R. D. (1989) Respiratory effects of brevitoxin and saxitoxin in awake guinea pigs. Toxicon 27, 647-654.
17. Galvan M., Grafe P. and Ten Bruggencate G. (1982) Convulsant actions of 4-aminopyridine on the guinea pig olfactory cortex slice. Brain Res. 241, 75-86.
18. Glover W. E. (1981) Cholinergic effect of 4-aminopyridine and adrenergic effect of 4-methyl-2-aminopyridine in cardiac muscles. Eur. J. Pharmac. 71, 21-31.
19. Glover W. E. (1982) The aminopyridines. Gen. Pharmac. 13, 259-285.
20. Hughes, J. M. (1979) Epidemiology of shellfish poisoning in the United States, 1971-1977. In: Toxic Dinoflagellate Blooms, pp. 23-28 (Taylor, D. L. and Seliger, H. H. Eds). New York/North-Holland, Holland: Elsevier.
21. Huot R. I., Armstrong D. L. and Chanh T. C. (1989) In vitro and in situ inhibition of the sodium channel blocker saxitoxin by monoclonal antibodies. J. Toxic. Environ. Hlth 27, 381-393.
22. Jaggard P. J. and Evans M. H. (1975) Administration of tetrodotoxin and saxitoxin into the lateral cerebral ventricle of the rabbit. Neuropharmacology 14, 345-349.
23. Kao C. Y. (1972) Pharmacology of tetrodotoxin and saxitoxin. Fed. Proc. 31, 1117-1123.
24. Kao C. Y., Suzuki T., Kleinhaus A. L. and Siegman M. J. (1967) Vasomotor and respiratory depressant actions of tetrodotoxin and saxitoxin. Arch. int. Pharmacodyn. Thér. 165, 438-450.
25. Kaufman B., Wright D. C., Ballou W. P. and Monheit D. (1991) Protection against tetrodotoxin and saxitoxin by a cross-protective rabbit antitetrodotoxin antiserum. Toxicon 29, 581-587.
26. Lundh H. (1978) Effects of 4-aminopyridine on neuromuscular transmission. Brain Res. 153, 307-318.
27. Lundh H., Nilsson O. and Rosen I. (1977) 4-Aminopyridine - a new drug tested in the treatment of Eaton-Lambert Syndrome. J. Neurol. Neurosurg. Psychiat. 40, 1109-1112.
28. Lundh H., Nilsson O. and Rosen I. (1979) Effects of 4-aminopyridine in myasthenia gravis. J. Neurol. Neurosurg. Psychiat. 42, 171-175.
29. Lyn P. C.W. (1985) Puffer fish poisoning: four case reports. Med. J. Malaysia 40, 31-34.
30. Miller R. D., Booij L. H., Agoston S. and Crul J. F. (1979) 4-Aminopyridine potentiates neostigmine and pyridostigmine in man. Anesthesiology 50, 416-420.
31. Molgó J., Lemeignan M. and Lechat P. (1977) Effects of 4-aminopyridine on frog neuromuscular junction. J. Pharmac. exp. Ther. 203, 653-663.
32. Murtha E. F. (1960) Pharmacological study of poisons from shellfish and puffer fish. Ann. N.Y. Acad. Sci. 90, 820-836.
33. Pelhate M. and Pichon Y. (1974) Selective inhibition of potassium current in the giant axon of the cockroach. J. Physiol. 242, 90-91.
34. Rodrigue D. C., Etzel R. A., Hall S., De Porras E., Valezquez O. H., Tauxe R. T., Kilbourne E. M. and Blake P. A. (1990) Lethal paralytic shellfish poisoning in Guatemala. Am. J. Trop. Med. Hyg. 42, 267-271.
35. Rutecki P. A., Lebeda F. J. and Johnston D. (1987) 4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition. J. Neurophysiol. 57, 1911-1924.
36. Sobek V. (1970) On the pharmacology of 4-aminopyridine compared with adrenaline. Physiol. Bohemoslovaca. 19, 417-419.
37. Stoyanov E., Vulchev P., Shturbova M. and Marinova M. (1976) Clinical electromyomechanicographic and electromyographic studies in decurarization with pymadine. Anaesth. Resus. Inten. Ther: 4, 139-142.
38. Sutherland, S. K. (1983) Australian Animal Toxins. Melbourne: Oxford University Press.
39. Szente M. B. and Baranyi A. (1989) Properties of depolarizing plateau potentials in aminopyridine-induced ictal seizure foci of cat motor cortex. Brain Res. 495, 261-270.
40. Valenti, M., Pasquini, P., and Andreucci, G. (1979) Saxitoxin and tetrodotoxin intoxication - Report of 16 cases. Vet. Human Toxic. 21(S), 107-110.
41. 2 stimulating action on respiration in cats. J. Pharmac. exp. Ther. 92, 187-195.
42. Watabe S., Sato Y., Nakaya M., Hashimoto K., Enomoto A., Kaminogawa S. and Yamauchi K. (1989) Monoclonal antibody raised against tetrodonic acid, a derivative of tetrodotoxin. Toxicon 27, 265-268.
43. Yanagisawa T. and Taira N. (1979) Positive inotropic effect of 4-aminopyridine on dog ventricular muscle. Naunynschmiedeberg's Arch. Pharmacol. 307, 207-212.
44. Yeh J. Z., Oxford G. S., Wu C. H. and Narahashi T. (1976) Interactions of aminopyridines with potassium channels of giant squid axon membranes. Biophys. J. 16, 77-81.